Nxera Pharma's oral receptor agonist advances in schizophrenia trials with successful preclinical milestone 16-Apr-2024 By Liza Laws Nxera Pharma Co., Ltd is celebrating a significant milestone in its collaboration with Neurocrine Biosciences Inc.